The report on Drug Discovery Technologies Market by technology type (biochips, high throughput screening, pharmacogenomics, genomics, bioanalytical instruments, bioinformatics, nanotechnology), end users (biopharmaceutical, pharmaceutical, research institutes and biotech companies) trends analysis and forecasts up to 2024 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Drug Discovery Technologies Market is projected to grow at a CAGR of 18.4% in terms of value over the period of 2018-2024. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
Drug Discovery Informatics Market size was USD 1.6 billion in 2015 and is anticipated to reach around USD 6.5 billion by 2023. Get more details @ https://goo.gl/UgKpgf
The report covers the analysis of global as well as regional markets of Drug Discovery Technologies. Moreover, the report gives insights into the factors that affect the global as well as regional performance of the market in the short run and in the long run.
The global artificial intelligence (AI) in drug discovery market size is expected to reach USD 4.05 billion by 2028 according to a new study by Polaris Market Research.
Major players in the artificial intelligence (AI) in drug discovery market are IBM Corporation, Microsoft, Atomwise Inc., Deep Genomics...... @ @ https://bit.ly/3D4dtix
This report studies the global Drug Discovery Services market, analyzes and researches the Drug Discovery Services development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
The global drug discovery informatics market size is expected to reach USD 5.62 billion by 2028 according to a new study by Polaris Market Research. The report “Drug Discovery Informatics Market Share, Size, Trends, Industry Analysis Report, By Workflow (Discovery Informatics, Development Informatics); By Mode (Outsourced, In-house); By Services (Sequence Analysis Platforms, Molecular Modeling, Docking, Clinical Trial Data Management, Others); By Regions; Segment Forecast, 2021 – 2028”
The global artificial intelligence (AI) in drug discovery market is expected to grow from $0.36 billion in 2020 to $0.47 billion in 2021 at a compound annual growth rate (CAGR) of 30.6%.
Major players in the artificial intelligence (AI) in drug discovery market are IBM Corporation, Microsoft, Atomwise Inc., Deep Genomics, Cloud Pharmaceuticals... @@ https://bit.ly/3y2JLrb
The Business Research Company added a report “Artificial Intelligence (AI) In Drug Discovery Market” to its collection – which covers the industry overview with size, share, development, demand and distribution. https://bit.ly/2EcMAyX
Global drug discovery informatics market was valued approximately US$ 2.0 Bn in 2016 and is anticipated to register CAGR of over 17.0% from 2017 to 2025 to reach value of approximately US$ 7.8 Bn by 2025.
Bharat Book Bureau provides the report; on “ADME/Tox Technologies Market Research Reports”. This Report on Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered. https://www.bharatbook.com/biotechnology-market-research-reports-227827/adme-tox-technologies1.html
Big Market Research “Global Drug Discovery Informatics Market 2022” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast
The global market for RNAi drug delivery technologies reached nearly $9.3 billion in 2012 and nearly $11.7 billion in 2013. This market is expected to grow to $38.8 billion in 2018, with a compound annual growth rate(CAGR) of 27.2% from 2013 to 2018.
The global central nervous system drugs market was valued at around $71 billion in 2017. North America was the largest region in the central nervous system drugs market in 2017, accounting for nearly 40% market share. Read Report https://www.thebusinessresearchcompany.com/report/central-nervous-system-drugs-global-market-report-2018
Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which is a consequence of trauma, injury, or inflammation. The main difference between neuropathic and nociceptive pain is the absence of a continuous nociceptive input in neuropathic pain. Although the term neuropathic pain is used to describe a wide range of pain syndromes with varying etiologies, this report focuses on 3 distinct forms of NP: Painful diabetic neuropathy, Postherpetic neuralgia and trigeminal neuralgia. See Full Report @ bit.ly/ZrFcVR
Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction. The AED market is currently dominated by UCB’s Keppra and GlaxoSmithKline’s Lamictal. Although both drugs have experienced significant generic erosion, they form the mainstay of epilepsy treatment in the nine markets and will continue to have significant market share during the forecast period. See Full Report @ bit.ly/1vM6jVN
Get more information about the market: http://bit.ly/2ywjaVx Generic drugs are considered as bioequivalent of branded drugs as they are similar in terms of quality, strength, dosage and intended use. They require low capital investment as they only incur the manufacturing cost without the expenditure on drug discovery, drug development, advertising, distribution of free samples, etc. Want more information about this market? Request a free report sample: https://www.imarcgroup.com/request?type=report&id=549&flag=B Contact Us IMARC Group USA: +1-631-791-1145 Email: sales@imarcgroup.com Website: https://www.imarcgroup.com Follow us on twitter: @imarcglobal
Biomarker technology is evidencing increased application from key segments such as disease diagnosis, drug development and formulation, diagnosis for exposure of certain harmful chemical and prognostic treatments. See Full Report @ http://bit.ly/1zB1l1W
The Global Wound Cleanser Products Market will be worth USD 1.97 billion by 2027, according to the latest analysis by Emergen Research. The growth of the market has been increasing at a considerable pace because of the growing demand for accurate and dependable wound care products to treat both acute and chronic wounds.
The global CRISPR Technology Market is projected to reach USD 3.94 billion by 2027, according to a recent report by Emergen Research. Certain factors that are driving the market growth include increasing government and personal funding, rising demand and adoption of CRISPR, and technological advancements.
Latest research report “Bioinformatics Market” published by TBRC provides Market Analysis Forecast, Size, Trends, Key Players, Segments and Growth. Read Full Report: http://bit.ly/2lyDCSP Request a Sample: http://bit.ly/2kqQLgz
Rising awareness about cell culture media has led to the rise in its demand, adoption and conclusively a rise in its market value. Data Bridge Market Research analyses that the cell culture media will exhibit a CAGR of around 8.18% for the forecast period of 2021-2028. https://www.databridgemarketresearch.com/reports/global-cell-culture-media-market
Glycomics refers to an extensive study of the physiological, genetic, and pathological, among other aspects of glycomas. Glycomics kit includes glycan release kits, glycan purification kits, and glycan labelling kits among others. These are highly deployed in applications such as oncology, drug & discovery & development, diagnostics, and immunology, among others.
The global osteoporosis drugs market is witnessing significant growth due to rising geriatric population and changing lifestyles impinging bone health. Prevalence of osteoporosis is high among people aged 60 years and above. Moreover, increasing the prevalence of osteoporosis in postmenopausal women, growing awareness about osteoporotic care, and increasing investment in drug discovery and development are also driving the growth of the market.
Statistics of Animal Model Market covering market size, industry share numbers, regional outlook, competitive landscape with data about leading companies is now available in the latest report by Global Market Insights, Inc.
In this report, the global metabolomic market is segmented by product and service, application, indication, and region. Download Sample at http://bit.ly/2L5dXcj . Based on product and service, this market is further segmented into two major segments—metabolomics instruments and metabolomics bioinformatics tools & services. Based on metabolomics instruments, the market is further segmented into detection tools and separation tools.
Avail more information from Sample Brochure of report @ http://bit.ly/2dlXJ2P The study covers and analyses “Global Mammalian Market”. Bringing out the complete key insights of the industry, the report aims to provide an opportunity for players to understand the latest trends, current market scenario, government initiative and technologies related to the market. In addition, it will help the venture capitalist in understanding the companies better and take informed decisions. Read analysis @ http://bit.ly/2cYaYDP
Breakthrough therapy designation and orphan drug approvals for microbiome therapeutics is expected to accelerate the launch of developmental drugs in the microbiome therapeutics market. A huge pipeline with over 120 candidates in different stages of development further creates the platform for potential growth of the microbiome therapeutics market.
According to a new market report published by Persistence Market Research “Global Market Study on Osteoporosis Drugs: Asia Pacific to Witness Highest Growth by 2022”, the global osteoporosis drugs market is estimated to be valued at US$11,226.1 Mn by the end of 2015 and is expected to expand at a CAGR of 4.0% from 2014 to 2022, to account for US$14,786.7 Mn by 2022.
This report provides comprehensive information on the therapeutic development for Growth Hormone Deficiency, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Growth Hormone Deficiency and special features on late-stage and discontinued projects. Enquiry @ http://www.researchbeam.com/growth-hormone-deficiency-pipeline-review-h2-2015-market/enquire-about-report
According to a new market report published by Persistence Market Research “Global Market Study on Osteoporosis Drugs: AsiaPacific to Witness Highest Growth by 2022”, the global osteoporosis drugs market is estimated to be valued at US$11,226.1 Mn by the end of 2015 and is expected to expand at a CAGR of 4.0% from 2014 to 2022, to account for US$14,786.7 Mn by 2022.
Increased spending in cancer-related research and development by various governments and private and commercial organizations combined with investments in anti-cancer drugs are the two key factors anticipated to heighten the generic oncology drugs demand, through 2019, as indicated in a recent market analysis of generic oncology drugs, by Persistence Market Research (PMR).
Expanding at a rather high CAGR of nearly 6.7 percent, small molecule generic oncology drugs, combing the efficacies of chemotherapy and immunotherapies could boost the ongoing cancer treatment modalities.
The report provides drug profiles which include product description, MOA, technology, licensors & collaborators, development partner and detailed chemical information.
The market is driven by factors, such as technological advancements and innovations, increasing compliance for drug discovery processes, and high demand for organ and tissue transplantation.
The global hospital supplies market was valued at above $31 billion in 2017. Read More: https://www.thebusinessresearchcompany.com/report/hospital-supplies-global-market-report-2018
Download Sample Brochure @ http://bit.ly/2dEhRvj DelveInsight’s, “ Xerostomia-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Xerostomia. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Read Analysis @ http://bit.ly/2dwYulS
Flow cytometry is a biophysical, laser based analytical technology that measures and analyses several physical characteristics of cells or particles suspended in a fluid, when passed through a laser beam. Flow cytometry has various advantages over traditional analytical methods such as ELISA, which include its ability to deliver precise and accurate results and lesser time consumption at about same prices.
Download Sample Brochure @ http://bit.ly/2cUzvLT Cardiovascular Inflammation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. Read Analysis @ http://bit.ly/2dxrN8n
Analyze Future: Leukemia Treatment Drugs Markets in China To Get More Details @ http://www.analyzefuture.com/leukemia-treatment-drugs-in-china-market China's demand for Leukemia Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.
MarketreportsonIndia.com presents the latest report on “Market Research Report on Biotechnology in India”. The report serves as a guide to Indian Biotechnology industry, as it covers more than 300 companies that are engaged in biotechnology R&D, discovery, testing and supply of products and services. http://www.marketreportsonindia.com/life-sciences-market-research-reports-12514/biotechnology-in-india.html
The biochip market is expected to witness significant growth throughout the forecast period because of an increasing application of biochips in genomics, proteomics and drug discovery.
Global Digital Genome Market Information by Disease (cancer, diabetes), by End users hospitals, research laboratories) by application (diagnostics, drug discovery, academic research) - Forecast to 2027
Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment. Companion diagnostics market is still nascent, and it is projected to reach $3.5 billion by 2020 from a base value of $1.1 billion in 2013, growing at a CAGR of 20% during 2014 to 2020. The global companion diagnostic market is segmented based on indication, technology and geography (North America, Europe, Asia Pacific and LAMEA). Read the Complete Report @ http://www.researchbeam.com/companion-diagnostic-technologies-market